Apogee Therapeutics, Inc. (APGE)
NASDAQ: APGE · Real-Time Price · USD
74.94
+1.89 (2.59%)
At close: Mar 9, 2026, 4:00 PM EDT
74.94
0.00 (0.00%)
After-hours: Mar 9, 2026, 4:10 PM EDT
Apogee Therapeutics Market Cap
Apogee Therapeutics has a market cap or net worth of $5.16 billion as of March 9, 2026. Its market cap has increased by 167.07% in one year.
Market Cap
5.16B
Enterprise Value
4.18B
1-Year Change
167.07%
Ranking
Category
Stock Price
$74.94
Market Cap Chart
Since the IPO on July 14, 2023, Apogee Therapeutics's market cap has increased from $808.89M to $5.16B, an increase of 537.85%. That is a compound annual growth rate of 101.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 5.03B | -1.27% |
| Dec 31, 2025 | 5.09B | 97.62% |
| Dec 31, 2024 | 2.58B | 92.13% |
| Dec 29, 2023 | 1.34B | 65.86% |
| Jul 14, 2023 | 808.89M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immunovant | 5.43B |
| CRISPR Therapeutics AG | 5.42B |
| Celcuity | 5.32B |
| Caris Life Sciences | 5.25B |
| CG Oncology | 5.22B |
| Mirum Pharmaceuticals | 5.21B |
| Scholar Rock Holding | 5.20B |
| PTC Therapeutics | 5.20B |